Zhuifeng Gao Pain Relieving

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the protective film from the plaster should be removed prior to application. The plaster is to be applied to the affected area no more than 3 to 4 times daily.

For children under 2 years of age, it is recommended to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on irritated or damaged skin is prohibited due to the potential for exacerbating the condition.

• The product should not be applied to open wounds, as this may lead to infection or delayed healing.

• Individuals with a known allergy to any ingredient in this product must avoid its use to prevent allergic reactions.

Additionally, caution is advised to prevent contact with the eyes or mucous membranes, and tight bandaging or application of heat to the treated area should be avoided to reduce the risk of burns. The product should not be placed on extremely hairy areas of skin to minimize irritation during removal.

Warnings and Precautions

For external use only. This product contains natural rubber latex, which may cause allergic reactions in sensitive individuals.

General precautions must be observed to ensure safe use. The product should not be applied to irritated or damaged skin, nor should it be used on open wounds. Additionally, individuals with known allergies to any ingredient in this product should refrain from use.

Healthcare professionals should advise patients to discontinue use and consult a doctor if any of the following occur: the condition worsens; symptoms persist for more than 7 days; symptoms resolve and then recur within a few days; excessive skin irritation develops; gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, diarrhea, or skin rash manifest; or if the patient experiences actual pain, blistering, or burning after application (a warming or cooling sensation is expected). In cases where the product is used for arthritis pain, patients should seek medical advice if pain persists for more than 10 days, if redness is present, or if the patient is under 12 years of age.

It is crucial to keep this product out of reach of children to prevent accidental poisoning. In the event of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware that it is intended for external use only. There is an allergy alert associated with this product, as it contains natural rubber latex, which may lead to allergic reactions in susceptible individuals.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, persistence of symptoms beyond 7 days, recurrence of symptoms after initial improvement within a few days, or development of excessive skin irritation. Additionally, patients should seek medical advice if they experience nausea, vomiting, abdominal discomfort, diarrhea, or a skin rash.

It is important to note that while a warming or cooling sensation may be expected after application, patients should stop use and contact a doctor if they experience actual pain, blistering, or burning. For those using the product for arthritis-related pain, it is recommended to seek medical attention if pain persists for more than 10 days or if redness is observed. Special caution is advised when using this product in children under 12 years of age.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Zhuifeng Gao Pain Relieving (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a physician prior to use. For children aged 2 years and older, the protective film from the plaster should be removed before application to the affected area, which may be done no more than 3 to 4 times daily.

In cases of arthritis-related pain in children under 12 years of age, if pain persists for more than 10 days or if redness is present, medical advice should be sought. It is essential to keep this product out of reach of children to prevent accidental poisoning. In the event of ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, healthcare professionals are advised to exercise caution when prescribing this product to pregnant patients. Due to the lack of safety concerns, dosage modifications, or special precautions outlined in the insert, the potential risks and benefits should be carefully considered on a case-by-case basis. Women of childbearing potential should be informed of the uncertainties surrounding the use of this product during pregnancy and advised to consult their healthcare provider if they become pregnant or plan to become pregnant while using this product.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

It is crucial to document any instances of overdose and report them to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Serious side effects have been reported voluntarily or through surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated phone number for further evaluation and monitoring.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental poisoning. In the event of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed not to use the product on irritated or damaged skin, or on any wounds. It is essential to inform patients to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, patients should be made aware to stop using the product if they experience excessive skin irritation, nausea, vomiting, abdominal discomfort, diarrhea, or a skin rash.

Patients should also be cautioned to stop use and seek medical advice if they feel actual pain or experience blistering or burning after application, noting that a warming or cooling sensation is normal. When using this product for arthritis pain, patients should be advised to consult a doctor if pain persists for more than 10 days or if redness is present. Special attention should be given to patients using the product for children under 12 years of age, as they should seek medical advice before use.

Healthcare providers should remind patients to avoid contact with the eyes or mucous membranes while using the product. They should also be instructed not to bandage the area tightly or apply heat in the form of heating pads, hot water bottles, or lamps, as this increases the risk of serious burns. Furthermore, patients should be advised to avoid placing the product on extremely hairy areas of skin to prevent irritation during removal.

Finally, patients should be encouraged to consult a doctor or pharmacist if they have any concerns regarding the use of this product.

Storage and Handling

Plasters are supplied in a zip-lock pouch, which should be kept tightly closed to maintain product integrity. For optimal storage, plasters should be stored in a dry place at a temperature range of 15 to 30°C (59 to 86°F), away from direct sunlight to prevent degradation of the product.

Additional Clinical Information

The transdermal route of administration is indicated for patients aged 2 years and older, with application to the affected area not exceeding 3 to 4 times daily. For children under 2 years of age, consultation with a physician is recommended prior to use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Zhuifeng Gao Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)